NCT00003754View on ClinicalTrials.gov

Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1998

Primary Completion Date

July 31, 2001

Study Completion Date

July 31, 2001

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

cyclophosphamide

DRUG

thalidomide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003754 - Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers | Biotech Hunter | Biotech Hunter